Canada has joined Uruguay to become the second country in the world to legalize pot. What does the new federal law mean for private equity? TBD. Marijuana legalization up north did give me a reason to check in with Salveo Capital – which invests not in growers but in underlying services like testing technology for cannabis labs – to hear their two cents.
Read MoreTo get a handle on who's cutting early-stage deals in the fledgling industry, Business Insider pulled data from PitchBook and reached out to the top venture-capital firms (including Salveo Capital) in the industry.
Read MoreChicago-based cannabis investment firm Salveo Capital has participated in a $10 million Series A round for Front Range Biosciences, a Colorado-headquartered company focused on tissue-culture propagation of high-value crops.
Read MoreLeading agricultural biotech company (and a Salveo Capital portfolio company) closes largest ever U.S. cannabis biotech funding round.
Read MoreSalveo Capital, an alternative investment firm specializing in the legalized cannabis space, today announced the formation of its Advisory Board comprised of a select group of professionals who will provide guidance to the firm on various strategic matters.
Read MoreAs the legalized pot industry continues to see explosive growth, Salveo Capital is moving quickly to capture the one segment of the market it has deemed underserved.
Read MoreSalveo is participating in the funding round with firms that include Altitude Investment Management, Panther Opportunity Fund, Canopy Ventures, Tendaji Investments, PB Venture Group, Halley Venture Partners and FlatIron Group, according to a spokesman for Salveo.
Read MoreWith its cutting edge solutions and high quality products, PathogenDx represents an innovative and disruptive company that is changing the testing process for cannabis-related products as we know it,” said Jeffrey Howard, a Managing Partner at Salveo Capital. “We believe that as customers and growers continue to seek the
Read MoreCanada's Canopy Growth Corp is buying Toyko Smoke cannabis owner Hiku Brands Co Ltd for C$269.2 million ($205.3 million), the latest deal in a fast-consolidating sector ahead of legal recreational marijuana sales.
Read MoreThe conventional wisdom on Wall Street is that it’s impossible to time the market. Venture capitalists, however, know all too well that when investing in either startup companies or nascent industries, timing is everything. Nowhere is this more true, today, than in the emerging cannabis market.
Read More“Flow Kana has quickly scaled its business in a relatively short time and is a perfect example of how the cannabis industry is evolving,” said Michael Gruber, a Managing Partner at Salveo Capital. “Flow Kana’s dedication and partnership with local farmers in Mendocino and Humboldt counties in California is
Read MoreSalveo Capital support CNVest pitch competition held in conjunction with Terpenes and Testing conference in San Jose on April 9th
Read MoreInvesting in Cannabis panel with Michael Gruber discusses the different opportunities available in cannabis space, and important considerations for investors
Read MoreTokyo Smoke announces merger with DOJA and strategic investment from Aphria to create a leading lifestyle brand and retail-focused cannabis company.
Read MoreFront Range Biosciences (“FRB” or the “Company”) a leading agricultural biotech company that specializes in tissue culture propagation of high value crops, is pleased to announce it has raised $3 million in bridge round funding. This funding will go towards scaling FRB’s processes, as well as expansion into California and other legal cannabis states in the United States
Read MoreCannabis workforce compliance platform Wurk announced that it has raised $2 million more in an extended seed round to help develop its growing operation in pot country and beyond, bringing its raised total to $3 million.
Read MoreFront Range Biosciences (FRB), the agricultural biotechnology company for high value crops, announced today that it raised $1.5 million in funding.
Read MoreSalveo Capital is a private equity fund dedicated to supporting high growth businesses supporting the legal cannabis ecosystem, with a focus on companies across a few sectors: information, data & analytics; financial payments & services; medical products, formulations & delivery; ag-tech & grow systems; and business services.
Salveo has completed investments in Headset and Front Range Biosciences. Headset is a Washington state located firm providing key actionable analytics to manufacturers and retailers within the cannabis industry. Front Range is a biotechnology providing a cost effective method to produce disease-free clones.
Read MoreHeadset, Inc., a leading retail analytics firm for cannabis-related businesses, announced today it has closed $2.5 million in financing as it ramps up its sophisticated suite of data products.
Read MoreFor some funders, marijuana is not just about sewing their wild oats. Rather, they see the business potential of being early to what’s expected to be a highly profitable and long-lasting party.
Read More
